The present review provides an understanding of our current knowledge of the carcinogenic effect of low-dose radiation in man, and surveys the epidemiological studies of human populations exposed to nuclear explosions and medical radiation. Discussion centers on the contributions of quantitative epidemiology to present knowledge, the reliability of the dose-incidence data, and those relevant epidemiological studies that provide the most useful information for risk estimation of cancer induction in man. Reference is made to dose-incidence relationships from laboratory animal experiments where they may obtain, for problems and difficulties in extrapolation from data obtained at high doses to low doses, and from animal data to the human situation. The paper describes the methods of application of such epidemiological data for estimation of excess risk of radiation-induced cancer in exposed human populations and discusses the strengths and limitations of epidemiology in guiding radiation protection philosophy and public health policy.
INTRODUCTION
Cancer induction is the most important late somatic health effect of low-dose ionizing radiation [1] , and as the dose of radiation increases above low levels, the risk of cancer increases in exposed human populations. It is these observations that have been central to public concern about the potential health effects of low-level radiation and to the task of estimating risks and establishing standards for protection of the health of the public. Epidemiological surveys on exposed human populations presently provide the scientific basis for risk estimation, but the data are highly uncertain in regard to the forms of the dose-response relationships for radiationinduced cancer. This is especially the case with low-level radiation. Therefore, it has been necessary to estimate human cancer risk at low radiation doses primarily from observations at relatively high doses in human populations exposed to nuclear explosions and medical radiation. Since it is not known whether the cancer incidence observed at such high dose levels also applies to cancer induction at low dose levels, scientific disagreement can arise concerning the methods to be used for estimating the carcinogenic risk from low-level radiation.
The present paper reviews the relevant epidemiological surveys on radiation carcinogenesis in human populations exposed to nuclear explosions or medical radiation, describes the methods of application of such epidemiological data for estimation of excess cancer risk in these exposed populations, and discusses the strengths and limitations of epidemiology in guiding radiation protection philosophy and public policy.
WHAT DO WE KNOW ABOUT RADIATION CARCINOGENESIS?
The somatic effects of concern at low doses and low dose rates are those that may be induced by mutation in individual cells, singly or in small numbers. The most important of these is considered to be cancer induction. Current knowledge of the carcinogenic effect of radiation in man has been reviewed to two recent reports: the 1977 Report of the United Nations Scientific Committee on the Effects of Atomic Radiation (the 1977 UNSCEAR Report) and the 1980 Report of the National Academy of Sciences Committee on the Biological Effects of Ionizing Radiations (the BEIR III Report) [1, 2] . The epidemiological data analyzed in these reports derive mainly from the epidemiological studies of the Japanese atomic bomb survivors in Hiroshima and Nagasaki, from patients in England and Wales treated with X irradiation for ankylosing spondylitis, and from several other groups of people irradiated from external or internal sources, either for medical reasons or through occupational exposure. Both reports emphasize that cancers of the breast, thyroid, hemopoietic tissues, lung, and bone can be induced by radiation. Other cancers, including cancers of the stomach, pancreas, and pharynx, lymphatic cancer, and perhaps all tissues of the body, may also be induced by radiation. Both reports derive risk estimates in absolute and relative terms for low-dose, low-LET1 whole body exposure, and for leukemia, breast cancer, thyroid cancer, lung cancer, and other cancers. These estimates derive from exposure and cancer incidence data at high doses (most frequently greater than 50 rem)2 and at high dose rates (most frequently greater than 50 rem per minute) [1, 3] . There are no compelling scientific reasons to apply these values of risk per rem derived from high doses and high dose rates to the very low doses and low dose rates of concern in human radiation protection. In the absence of reliable human data for calculating risk estimates at very low doses and low dose rates, neither the UNSCEAR nor BEIR Committees felt confident enough to predict the reliability of such extrapolation [1] [2] [3] [4] .
Certain general principles of radiation carcinogenesis have now emerged based on the relatively large number of epidemiological surveys studied. First, the younger the exposed individual, from in utero exposure through adult life, the higher is the risk per rem for induction of most tumors. Second, the incidence of leukemia in exposed populations rises above normal within three to five years of exposure, and declines within 15 to [1] [2] [3] [4] [5] [6] [7] .
In spite of the uncertainties in dose-incidence relationships, the following important generalizations emerge from the extensive laboratory animal data available. The incidence of cancer is increased by irradiation; the dose-response curve rises with dose up to a certain dose level, above which it may reach a plateau and turn downward with further increase in dose. In the dose range over which the incidence increases with dose, low-LET radiations are usually more effective at high doses and high dose rates than at low doses and low dose rates. In the same dose range, high-LET radiations are usually more effective than low-LET radiations. For high-LET radiations, the effectiveness is influenced less by dose and dose rate, and, in some instances, protraction may increase their effectiveness. The relative biological effectiveness (RBE)4 of high-LET radiations tends to increase with decreasing dose and dose rate [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Because of wide species differences in response in laboratory animals, the cancer dose-incidence response for any species cannot provide a reliable basis for direct quantitative risk estimates for cancer induction in man. Furthermore, variations in the shapes of dose-incidence curves for different radiationinduced neoplasms in laboratory animals confound extrapolation from one type of 3Rad is the unit of absorbed dose of radiation = 100 ergs/g. 4Relative biological effectiveness (abbr. RBE) is defined as the ratio of the absorbed radiation dose of high-LET radiation which produces the same biological effect as that due to a dose of low-LET radiation.
neoplasms to another, from any one set of exposure conditions to another, or from any one animal species to another, particularly to man.
WHAT CAN WE LEARN FROM HIGH-DOSE DATA FOR EXTRAPOLATION TO LOW DOSES?
Because of the difficulty of obtaining reliable cancer-incidence data in laboratory animals and in humans for low doses, for purposes of risk estimation dose-response relationships observed at high doses must necessarily be extrapolated into the lowdose region, where reliable human epidemiological data are not available. It is impossible to ascertain the true shape of the dose-effect curve at low dose levels, and therefore the mechanism of radiation action in the low-dose levels, and therefore the mechanism of radiation action in the low-dose region [1] . Consideration of the spatial and temporal distribution of ionizations suggests that at very low dose levels, the probability of interaction of ionizing events is negligible. Here, the molecular and cellular response to radiation at very low doses must be linear with dose, irrespective of the shape of the dose-response curve at higher doses. It is reasonable, as well, that the dose-response relationship for cancer incidence at very low doses will be linear, irrespective of the complexity of the carcinogenic process.
The recent conclusion of the BEIR Committee [1] , and those of the NCRP5 [9, [5, 7, 9, 13] .
In recent years, a general hypothesis for estimation of excess cancer risk in irradiated human populations, based on theoretical considerations, on extensive laboratory animal studies, and on limited epidemiological surveys, suggests various and complex dose-response relationships between radiation dose and observed cancer incidence [7, [13] [14] [15] [16] . One of the most widely considered models for cancer induction by radiation, based on the available information and consistent with both knowledge and theory, takes the complex quadratic form: I(D) = (to + a,D + a2D2) exp (-f1D -2D2), where I is the cancer incidence in the irradiated population at radiation dose D in rad, and a0, Cal, C!2, f1, and 2 are non-negative constants (Fig. 1 [1, 3, 7, 9, (Fig. 2) . WHAT These studies are attempting to answer the important questions, with direct bearing on estimation of the cancer risk in human populations exposed to low-dose levels. The magnitude of risk of induction of all types of tumors in relation to dose and time since exposure require careful evaluation. The excess risk of leukemia following irradiation increased with dose; after high doses it was evident within three to four years after radiation and declined within 15 years, but persisted for 25 years or more after exposure [17] [18] [19] . At present, there continues to be a large increase in the radiation-induced cancer death rate during the ten-year period 1965 to 1974, up to 30 years after exposure. This increase is particularly evident in solid tumor induction; there is presently no indication of a return to normal levels of the mortality rates from these cancers. Cancers are occurring in excess in the surviving irradiated population, due mainly to extremely long latent periods after exposure before these solid tumors are detected. Recently, certain cancers not previously thought to be radiation-induced are appearing in excess in the irradiated population. And finally, the method of radiation action -whether to multiply or to add to spontaneous levels of the cancer death rate -is essential information for projecting the long-term carcinogenic effects in persons irradiated as children or young adults.
Present cancer risk estimates predicted to occur as a result of low-dose exposure of human populations to radiation rely on assumptions about these important questions and on assumptions on the method of extrapolation from human data obtained at high doses to low doses. At the present time, estimated excess cancer rates are derived from observations on Japanese A-bomb survivors of Hiroshima and Nagasaki averaged over the period 1960 to 1974. The excess cancer death rate of these survivors could rise, remain the same, or decrease during the coming years. For leukemia induction in the Nagasaki survivors, the Life Span Study (LSS)8 death certificate data appear consistent with a quadratic dose-incidence relationship (Fig. 3) . The shape of the Nagasaki curve is considered a strong determinant of the value for the RBE for neutrons derived from the Hiroshima (neutron-rich) and Nagasaki (neutron-deficient) exposure [17, 19] .
The leukemia dose-response curves in the LSS sample and the Leukemia Registry in the two cities are compared in Fig. 3 [17] . An apparent curvilinear relationship in the low-dose region results from the sparsity of leukemia cases in the Nagasaki LSS sample below 100 rads kerma; this relationship is much less marked when all the Registry cases are used. The leukemia incidence in the Nagasaki LSS sample is less than in the Hiroshima survivors at all doses except in the 0-9 rad group. This increased incidence in the Hiroshima survivors implies a greater RBE for neutrons for leukemia induction than gamma rays, and the neutron RBE is greater than one. The curvilinearity in the Nagasaki sample indicates that the neutron RBE increases as the "Life Span Study (abbr. LSS) of the Japanese atomic-bomb survivors; sample consists of 109,000 persons, of whom 82,000 were exposed to the bombs, mostly at low doses.
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Another population that received irradiation as a result of a nuclear explosion was the Marshall Islanders, who were exposed to fallout from an H-bomb test explosion in 1954 [20] . In this population, the main health effects came from short-lived fission iodine radioisotopes; this has contributed to our knowledge of risk estimates for thyroid cancer following irradiation. However, the data on the Marshallese are difficult to analyze, primarily because their radiation exposures were to a mixture of high dose rate external and internal gamma photons, as well as to beta radiation.
Medical Radiation Exposures
The initial reports of Stewart and her colleagues [21] described an excess of leukemia and all other cancers among children irradiated in utero when their mothers received diagnostic pelvic X irradiation during the pregnancy. The two largest studies [22, 23] indicated that diagnostic pelvic X-ray examinations during pregnancy resulted in an increase of approximately 50 percent in cancer mortality among the children during the first ten years of life. Because the doses involved an average dose to the fetus of about 1 rad, these surveys are extremely important to radiation protection of the general population. However, failure to confirm these results in the children of the Japanese women who were exposed to atom-bomb radiation in Hiroshima and Nagasaki, and the inability to reproduce the result in laboratory animals, has led to the questioning of whether radiation alone is the etiologic agent in the human surveys [38] .
Several other human populations exposed to diagnostic X-rays have been studied. Multiple diagnostic exposure to adult males appears to be associated with the increased risk of developing leukemia [23] . The risk estimates for leukemia induction from this study are similar to those obtained from data at high doses of radiation.
Studies that increase the precision of risk estimates for induction of breast cancer are those of a follow-up of pulmonary tuberculosis patients for whom the treatment of choice prior to 1950 was artificial pneumothorax, which was associated with repeated fluoroscopic exposures. The initial surveys of female patients treated in a Nova Scotia sanatorium between 1940 and 1949 [24, 25] indicated that despite the uncertainty of the radiation dose estimates and the extreme fractionation of the total dose, the risk per rad for breast cancer induction is large and very similar to singleexposure studies, in which high doses were absorbed by the breast tissue [17] . These data appear consistent with a linear dose-incidence relationship [16] (Fig. 4) . Important information has been obtained from persons who have been irradiated either externally or by internal emitters for therapeutic reasons. Court-Brown and Doll [26] analyzed the data on leukemia and all other cancers in over 14,000 patients with ankylosing spondylitis who received external irradiation from 1935 to 1954 in the United Kingdom. The leukemia data in these patients are in reasonably good agreement with those from the Japanese A-bomb survivors. Another study of patients irradiated for ankylosing spondylitis and other diseases is that of Spiess and Mays [27, 28] ; here, the patients received intravenous injections of the bone-seeking alpha-emitter radium-224. The evidence indicates that the younger patients are slightly more susceptible to the induction of bone sarcomas for equal protraction periods and that the data are consistent with a quadratic dose-incidence relationship.
Irradiation for medical reasons often introduces uncertainties into the interpreta- tion of data from patients, particularly the potential influence of the disease for which the patients were treated. Furthermore, analysis of the dose-incidence relationships for carcinogenesis by internal emitters is complicated by several sources of uncertainty relating to variations in the spatial and temporal distribution of the dose, which are, in turn, dependent on the uptake, disposition, metabolism, and elimination of the radionuclide [1] [2] [3] [4] [5] [6] [7] [8] 29] . In most patients, the initial dose, dose rate, and patterns of radionuclide excretion are unknown. Furthermore, the radioactivity in these individuals may be deposited nonuniformly in bone, and concentrated in hot spots where the dose at the center is very much higher than that in surrounding bone [29] .
Occupational Exposures
Valuable epidemiological surveys exist on populations of workers exposed as a result of their occupations; these include, for example, uranium and fluorspar miners, radiologists, radium-dial painters, and workers in the processing of plutonium [1] [2] [3] [4] . Some of these groups have been followed for many years. Important data are available in spite of the complexities of long-term epidemiological studies, such as mobility of populations, nonuniformity of occupational histories, There are populations exposed to lifetime doses of very high natural background radiation; two are those living in the monazite sands regions of Brazil and India, where they have resided for many generations. Attempts to obtain reliable epidemiological data from these populations have failed due primarily to the complications of collecting human epidemiological data and further confounded by local cultural, religious, and political practices.
Natural background radiation may vary from one geographic region to the next [1] . Attempts to correlate background dose with human epidemiological data are confounded by errors and lack of uniformity in the dosimetric estimates of radiation levels, and by varying quality of vital statistics information among the various communities, states, regions, and countries [1] [2] [3] [4] . The sources of bias introduced by these factors have thus far been greater than differences that are likely to be of any value.
WHAT ARE THE SOURCES OF EPIDEMIOLOGICAL DATA FOR THE ESTIMATION OF EXCESS CANCER RISK IN EXPOSED HUMAN POPULATIONS?
The tissues and organs about which we have the most reliable epidemiological data on radiation-induced cancer in man, obtained from a variety of sources from which corroborative risk coefficients have been estimated, include the bone marrow, the thyroid, the breast, and the lung [1, 2] . The data on bone and the digestive organs are, at best, preliminary, and do not approach the precision of the others. For several of these tissues and organs, risk estimates are obtained from very different epidemiological surveys, some followed for over 30 years, and with adequate control groups. There is good agreement when one considers the lack of precision inherent in the statistical analyses of the case-finding and cohort study populations, variability in ascertainment and clinical periods of observation, age, sex, and racial structure, different radiation dose levels, and constraints on data from control groups.
The most reliable data have been those of the risk of leukemia, which come from the Japanese atomic bomb survivors [17, 18, 38] , the ankylosing spondylitis patients treated with X-ray therapy in England and Wales [26] , the patients treated with radiotherapy for benign uterine bleeding [30] , the patients treated with radiation for ringworm of the scalp [31] , and the early radiologists [32, 33] . There is evidence of an age dependence and a dose dependence, a relatively short latent period of a matter of a few years, and a relatively short period of expression, some ten years. This cancer is uniformly fatal.
The data on thyroid cancer are more complex. These surveys include the large series of children treated with radiation to the neck and mediastinum for enlarged thymus [34] , children treated to the scalp for tinea capitis [31] , and the Japanese atomic bomb survivors [17] and Marshall Islanders [20] exposed to nuclear explosions. Here, there is an age dependence and sex dependence-children and females appear more sensitive. Although the induction rate is high, the latent period is relatively short, and it is probable that no increased risk will be found in future follow-up of these study populations. In addition, most tumors are either thyroid nodules or benign or treatable tumors, and only a few are fatal.
Much information has become available on radiation-induced breast cancer in women [35, 39] . The surveys include primarily women with tuberculosis who received frequent fluoroscopic examinations for artificial pneumothorax [25] , postpartum mastitis patients treated with radiotherapy [36] , and the Japanese atomic bomb survivors in Hiroshima and Nagasaki [17] . Here, there is an age dependence and dose dependence, as well as a sex dependence. The latent period is long; 20 to 30 years. Perhaps about half of these neoplasms are fatal.
Another relatively sensitive tissue, and a complex one as regards radiation dose involving parameters of the special physical and biological characteristics of the radiation quality, is the epithelial tissue of the bronchus and lung. These surveys include the Japanese atomic bomb survivors [17] , the uranium miners in the United States and Canada [37] , and the ankylosing spondylitis patients in England and Wales [26] . There is some evidence of age dependence from the Japanese experience, and a relatively long latent period. This cancer is uniformly fatal.
The risk of radiation-induced bone sarcoma, based primarily on surveys of the radium and thorium patients who had received the radioactive substances for medical treatment, or persons who ingested these materials in the course of their occupations [28] Numerical estimation of the risk of radiation-induced cancer in man must necessarily be based primarily on human dose-incidence data. However, risk estimation at very low doses and low dose rates at present must also necessarily depend on extrapolation from observations at higher doses and higher dose rates, based on assumptions about the dose-incidence relationships and the mechanisms of carcinogenesis. Improvements in our knowledge of the carcinogenic effectiveness of ionizing radiation will depend on the elucidation of mechanisms of carcinogenesis, especially at the very earliest stages of malignant transformation, and on the provision of empirical dose-incidence data for low doses both in human populations and in laboratory animals experiments, insofar as this is possible.
And finally, we must conclude that the estimation of the carcinogenic risk of lowdose, low-LET radiation is subject to numerous uncertainties. The greatest of these concerns is the shape of the dose-response curve. Others include the length of the latent period, the RBE for fast neutrons and alpha radiation relative to gamma and X radiation, the period during which the radiation risk is expressed, the model used in projecting risk beyond the period of observation, the effect of dose rate or dose fractionation, and the influence of differences in the natural incidence of specific types of cancer. In addition, uncertainties are introduced by the biological risk characteristics of humans; for example, the effect of age at irradiation, the influence of any disease for which the radiation was given therapeutically, and the influence of length of observation or follow-up of the study populations. The collective influence of these uncertainties is such as to deny great credibility to any estimates of human cancer risk that can be made for low-dose, low-LET radiation. Nevertheless, despite all the uncertainties I have chosen to discuss, there is greater knowledge of the risks of radiation than of any other potentially hazardous physical or chemical agent in the environment.
